C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
MJJ Equity

MJJ

OTCMKTS · MJJ

$73.21
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
42/100 composite
Fundamentals40
Regulatory55
Market40
Editorial30
Composite · trailing 12 months

Microsectors Cannabis 3x ETN, listed under the ticker MJJ, has been rated Neutral with a composite score of 42.2. Analysis of the sector reveals a moderate level of conviction, measured at two out of five, with diverse contributions from key pillars. The regulatory pillar stands out with the strongest influence, reflecting a favorable jurisdictional stance in the global ETF landscape. Meanwhile, the fundamentals, market, and editorial pillars contribute less significantly, each displaying constraints related to data availability and newsroom attention.

In examining the underlying dynamics of MJJ, it becomes evident that several pivotal data points are either lacking or minimal. The fundamental pillar is notably unrevealed, as no primary financial fundamentals have been made available, leaving the financial condition undefined. Regulatory analysis, however, sheds light on a strong compliance environment, with no recent enforcement actions or new regulatory filings. This solid regulatory backdrop contrasts with the absence of market data, as no trading quotes are available, and editorial interest remains muted with no recent coverage or news briefs.

Looking forward, the regulatory pillar provides the most substantial indicator due to its robust jurisdiction posture and enforcement profile. Monitoring changes in the global regulatory landscape for ETFs will be critical in evaluating potential shifts in the investment sentiment for MJJ. Any updates in regulatory filings or changes to the global jurisdictional stance can significantly alter the composite rating and the prospective performance outlook of this cannabis sector instrument.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
777 Brickell Ave Miami, FL 33131
Phone
1-877-369-5412
CEO
Greg King Founder
CFO
Robert Rokose
Website
Company website
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for MJJ (MJJ)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for MJJ (MJJ), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for MJJ are maintained by Cannabis Investor News and refreshed throughout the trading day.